Cannvas Creative Earns $128,000 of Revenue in Q2 – Generating Revenue in its First Quarter of Operations Through Third-Party Creative and Development Projects
Cannvas MedTech (CSE:MTEC), a leading business technology company within the cannabis space, is pleased to announce that Cannvas Creative Inc., a wholly owned and operated subsidiary, has secured over $150,000 of design and development projects and earned $128,000 in revenue in its first quarter of operations. Cannvas Creative is a brand new, results-oriented, full-service design and marketing agency that delivers on three core business drivers: strategy, design, and technology. The Creative team is led by Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc., who brings over 20 years of brand and design development, with a successful track record of building a number of creative agencies and digital companies.
Cannvas Creative is a results-driven, full-service design and marketing agency that delivers on three core business drivers: strategy, design, and technology. Every project begins with a blank canvas, and Cannvas Creative delivers expertise and creativity to create masterpieces that speak to our clients’ uniqueness and flair for beautifully designed solutions.
The Cannvas Creative team is made up of like-minded individuals that love to collaborate, innovate and venture outside the box. Marianne Musi is Cannvas Creative’s Marketing Director and an award-winning information designer who managing the day-to-day activities. Marianne is an expert at using her deep understanding of human-centered design and cognition to create compelling and resonant experiences that inspire consumer behavioral change. She has a passion for emerging technologies and world-class design drives her to continuously search for new ways to frame existing experiences.
Cannvas Creative is a trusted partner for brands with the need for strategy driven, results-oriented design and marketing solutions. For more information visit: www.cannvascreative.com.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.